Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Giaccone, Luisa  [Clear All Filters]
Journal Article
Coscia M, Vitale C, Cerrano M, Maffini E, Giaccone L, Boccadoro M, Bruno B. Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives. Front Biosci (Landmark Ed). 2019;24:1284-1315.
Malagola M, Polverelli N, Rubini V, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, et al. GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS. Transplant Cell Ther. 2021.
Schirico MLo, Passera R, Gill J, Dellacasa C, Dogliotti I, Giaccone L, Zompi S, Busca A. Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study. Cancers (Basel). 2023;15(10).
Mariotti J, Raiola AMaria, Evangelista A, Carella AMichele, Martino M, Patriarca F, Risitano A, Bramanti S, Busca A, Giaccone L, et al. Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy. Blood Adv. 2020;4(16):3900-3912.
Mariotti J, Raiola AMaria, Evangelista A, Harbi S, Patriarca F, Carella MAngelo, Martino M, Risitano A, Busca A, Giaccone L, et al. Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant. 2022.
Arduino PG, Gambino A, Giaccone L, Suria M, Carbone M, Carrozzo M, Broccoletti R, Conrotto D. Oral health status after hematopoietic stem cell transplantations: Outcomes from an adult Italian population. Spec Care Dentist. 2022.
Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao L-P, Berrocal JCarlos Cab, Sala C, Maggioni G, Bernardi M, et al. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes. J Clin Oncol. 2023:JCO2201784.
Busca A, Gabrielli G, Sidoti F, Costa C, Giaccone L, Dogliotti I, Dellacasa CMaria, Francisci T, Pecoraro C, Ruggeri M, et al. SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor. Bone Marrow Transplant. 2022.
Urbino I, Secreto C, Apolito V, Olivi M, Arrigo G, Boscaro E, Catania FMaria, D'Ardia S, Frairia C, Giai V, et al. Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience. Leuk Res. 2023:107421.
Aydin S, Passera R, Scaldaferri M, Dellacasa CMaria, Poggiu M, Cattel F, Zallio F, Brunello L, Giaccone L, Dogliotti I, et al. Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3-ITD-mutated acute myeloid leukemia. Int J Hematol. 2022.
van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KLung, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, et al. Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study. Lancet Oncol. 2023.